Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma
- 1Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
- 2Departments of Rehabilitation Medicine, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
- 3Merck & Co Inc, South San Francisco, CA, USA
Related
- From Payload‐First Toward Dual‐Mechanism Antibody–Drug Conjugates
- Antibody-drug conjugates in precision oncology
- Conditionally active antibody‒drug conjugates
- C11-conjugated soft glucocorticoid antibody–drug conjugates for precision immunomodulation
- Antibody-Drug Conjugates in Solid Tumor Oncology and the Frontier of Precision Immunosuppression: A Mechanistic, Translational, and Clinical Review
BibTeX
@article{han2026vitro,
title = {{133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma}},
author = {Mei Han and Bin Wang and Mengxuan Jia and Christina Shen and Ryan Quiroz and Jianzhong Wen and Ian Knemeyer},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0133},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0133},
note = {CC BY},
}
RIS
TY - JOUR
TI - 133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma
AU - Mei Han
AU - Bin Wang
AU - Mengxuan Jia
AU - Christina Shen
AU - Ryan Quiroz
AU - Jianzhong Wen
AU - Ian Knemeyer
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0133
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0133
SN - 2051-1426
ER -